COURSE NUMBER: MBA 297C.1

COURSE TITLE: Innovation in Healthcare

UNITS OF CREDIT: 2 Units

INSTRUCTOR: Jeff Rideout and Lisa Suennen

E-MAIL ADDRESS: jarideout@sbcglobal.net; lisasuennen@venturevalkyrie.com

MEETING DAY(S)/TIME: Thursdays, 4:00 – 6:00 PM

PREREQUISITE(S): Completion of one of the following classes or instructor consent:

·        Healthcare in the 21st Century (MBA 297A-1)

·        Venture Capital and Private Equity (MBA 295B)

·        New Venture Finance (MBA 295D)

CLASS FORMAT: Lecture, guest speakers, discussion

ABSTRACT OF COURSE'S CONTENT AND OBJECTIVES:

The purpose of this course is to provide students with insights into the newest innovations in healthcare service delivery, information technology, medical devices and life sciences and how venture and private equity investors evaluate and determine where to invest their money among these areas to maximize return, minimize risk, and capitalize on a highly fluid marketplace that represents nearly 20% of the U.S. GDP.  Through presentations by leading entrepreneurs in the field, students will be challenged to reach conclusions regarding which healthcare sectors are the most promising for venture investing and which individual companies presented reflect the best opportunities, particularly in light of the seismic shifts currently underway within the healthcare industry driven by both public and private considerations. This is not primarily a finance class, but more substantively about the nuances of emerging healthcare businesses and venture finance as applied to this very unique sector.

By the end of the course, students will:

· Understand how the market drives the innovation culture in healthcare

· Have insights into current innovations in health care across its four primary sectors:  biotech, medical devices, services and information technology

· Be able to analyze risks and opportunities in young healthcare companies and understand how companies are responding to and evolving as a result of changes in the healthcare system, including health reform

· Understand key aspects of venture capital operations as it pertains to healthcare venture capital

· Know how to apply criteria for healthcare venture capital investing

· Present their rationale for investing decisions

BIOGRAPHICAL SKETCH:

Jeff Rideout MD currently is an independent consultant operating through Rideout Advisors, LLC.  In this capacity Dr. Rideout serves as the Senior Medical Advisor for Covered California, the California Health Insurance Exchange and is also a Senior Advisor to GE Ventures.  Dr. Rideout was previously the Chief Medical Officer for Cisco Systems, Blue Shield of California and the TriZetto Group, and holds academic appointments with Stanford University as Consulting Professor, Department of Health Research and Policy, and the University of California, Berkeley Haas School of Business.

Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, which serves venture capital firms and healthcare companies.  Previously Lisa co-founded and was a partner at Psilos Group, a healthcare-focused venture capital firm. Earlier, Lisa helped build Merit Behavioral Care, an $800mm behavioral healthcare company. Lisa is a board member at multiple healthcare entities and writes Venture Valkyrie, a widely read blog on healthcare and investing. In 2014 she published a book on healthcare IT called Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology. Lisa holds undergraduate and graduate degrees from UC Berkeley, where she is now on faculty at the Haas School of Business.